DE60232018D1 - 3-phenyl-2-arylalkylthiopropionsäure-derivate als selektive agonisten von ppar-alpha - Google Patents
3-phenyl-2-arylalkylthiopropionsäure-derivate als selektive agonisten von ppar-alphaInfo
- Publication number
- DE60232018D1 DE60232018D1 DE60232018T DE60232018T DE60232018D1 DE 60232018 D1 DE60232018 D1 DE 60232018D1 DE 60232018 T DE60232018 T DE 60232018T DE 60232018 T DE60232018 T DE 60232018T DE 60232018 D1 DE60232018 D1 DE 60232018D1
- Authority
- DE
- Germany
- Prior art keywords
- ppar
- alpha
- phenyl
- acid derivatives
- selective agonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0104333A SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Therapeutic agents |
| PCT/GB2002/005743 WO2003051826A1 (en) | 2001-12-19 | 2002-12-18 | 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60232018D1 true DE60232018D1 (de) | 2009-05-28 |
Family
ID=20286432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60232018T Expired - Lifetime DE60232018D1 (de) | 2001-12-19 | 2002-12-18 | 3-phenyl-2-arylalkylthiopropionsäure-derivate als selektive agonisten von ppar-alpha |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7276539B2 (de) |
| EP (1) | EP1458677B1 (de) |
| JP (2) | JP3810770B2 (de) |
| KR (1) | KR20040068589A (de) |
| CN (1) | CN100343229C (de) |
| AR (1) | AR038046A1 (de) |
| AT (1) | ATE428691T1 (de) |
| AU (1) | AU2002352426A1 (de) |
| BR (1) | BR0215090A (de) |
| CA (1) | CA2470066C (de) |
| CO (1) | CO5590908A2 (de) |
| DE (1) | DE60232018D1 (de) |
| ES (1) | ES2324025T3 (de) |
| HK (1) | HK1068866A1 (de) |
| HU (1) | HUP0402093A3 (de) |
| IL (1) | IL162378A0 (de) |
| IS (1) | IS7303A (de) |
| MX (1) | MXPA04005992A (de) |
| NO (1) | NO20043084L (de) |
| NZ (1) | NZ533365A (de) |
| PL (1) | PL370623A1 (de) |
| RU (1) | RU2004117776A (de) |
| SE (1) | SE0104333D0 (de) |
| TW (1) | TW200410678A (de) |
| UA (1) | UA80407C2 (de) |
| WO (1) | WO2003051826A1 (de) |
| ZA (1) | ZA200404585B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1517883B8 (de) | 2002-06-20 | 2008-05-21 | AstraZeneca AB | Ortho-substituierte benzoesäurederivate zur behandlung von insulinresistenz |
| GB0314131D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314130D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314075D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314134D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314260D0 (en) * | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0427524D0 (en) * | 2004-12-16 | 2005-01-19 | Astrazeneca Ab | Chemical process |
| GB0427701D0 (en) * | 2004-12-17 | 2005-01-19 | Astrazeneca Ab | Therapeutic agents |
| RU2480453C2 (ru) | 2007-03-08 | 2013-04-27 | Альбирео Аб | Новые соединения |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| US5232945A (en) * | 1992-07-20 | 1993-08-03 | Pfizer Inc. | 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives |
| WO1999029640A2 (en) | 1997-12-05 | 1999-06-17 | Eisai Co., Ltd. | Compositions and methods for modulating the activity of fibroblast growth factor |
| KR100620337B1 (ko) * | 1998-03-10 | 2006-09-13 | 오노 야꾸힝 고교 가부시키가이샤 | 카르복실산 유도체와 그 유도체를 유효 성분으로서함유하는 약제 |
| SE9801990D0 (sv) | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
| MA26634A1 (fr) | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
| SE9801992D0 (sv) | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
| GB9822473D0 (en) * | 1998-10-16 | 1998-12-09 | Glaxo Group Ltd | Chemical compounds |
| EP1177187B1 (de) | 1999-04-28 | 2007-07-25 | Sanofi-Aventis Deutschland GmbH | Di-aryl-säurederivate als ppar rezeptor liganden |
| TWI262185B (en) * | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
| SE9904421D0 (sv) | 1999-12-03 | 1999-12-03 | Astra Ab | New compounds |
| TW574193B (en) | 1999-12-03 | 2004-02-01 | Astrazeneca Ab | Novel phenalkyloxy-phenyl derivatives, pharmaceutical composition containing the same and their uses |
| SE0000772D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | Chemical compounds |
| KR20020081424A (ko) | 2000-03-09 | 2002-10-26 | 아벤티스 파마 도이칠란트 게엠베하 | Ｐｐａｒ 매개인자의 치료학적 용도 |
| SE0003766D0 (sv) | 2000-10-18 | 2000-10-18 | Astrazeneca Ab | Novel formulation |
| EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
| TWI311133B (en) | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
| SE0101978D0 (sv) | 2001-06-01 | 2001-06-01 | Astrazeneca Ab | New compounds |
| GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
| GB0121621D0 (en) * | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| CN1582151A (zh) | 2001-09-08 | 2005-02-16 | 阿斯特拉曾尼卡有限公司 | 用于治疗高脂血症、具有回肠胆汁酸转运(ibat)抑制活性的苯并硫氮杂䓬和苯并硫杂二氮杂䓬衍生物 |
| SE0104334D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| GB0229931D0 (en) | 2002-12-21 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
| GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
| SE0201936D0 (sv) | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
| SE0201937D0 (sv) | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
| EP1517883B8 (de) | 2002-06-20 | 2008-05-21 | AstraZeneca AB | Ortho-substituierte benzoesäurederivate zur behandlung von insulinresistenz |
| GB0314136D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314078D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314129D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314131D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314130D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314075D0 (en) | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314260D0 (en) | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
-
2001
- 2001-12-19 SE SE0104333A patent/SE0104333D0/xx unknown
-
2002
- 2002-12-18 MX MXPA04005992A patent/MXPA04005992A/es not_active Application Discontinuation
- 2002-12-18 PL PL02370623A patent/PL370623A1/xx unknown
- 2002-12-18 CN CNB028281225A patent/CN100343229C/zh not_active Expired - Fee Related
- 2002-12-18 US US10/499,042 patent/US7276539B2/en not_active Expired - Fee Related
- 2002-12-18 AU AU2002352426A patent/AU2002352426A1/en not_active Abandoned
- 2002-12-18 HU HU0402093A patent/HUP0402093A3/hu unknown
- 2002-12-18 KR KR10-2004-7009348A patent/KR20040068589A/ko not_active Application Discontinuation
- 2002-12-18 AT AT02788144T patent/ATE428691T1/de not_active IP Right Cessation
- 2002-12-18 RU RU2004117776/04A patent/RU2004117776A/ru not_active Application Discontinuation
- 2002-12-18 DE DE60232018T patent/DE60232018D1/de not_active Expired - Lifetime
- 2002-12-18 IL IL16237802A patent/IL162378A0/xx unknown
- 2002-12-18 ES ES02788144T patent/ES2324025T3/es not_active Expired - Lifetime
- 2002-12-18 WO PCT/GB2002/005743 patent/WO2003051826A1/en active Application Filing
- 2002-12-18 CA CA002470066A patent/CA2470066C/en not_active Expired - Fee Related
- 2002-12-18 EP EP02788144A patent/EP1458677B1/de not_active Expired - Lifetime
- 2002-12-18 NZ NZ533365A patent/NZ533365A/en unknown
- 2002-12-18 BR BR0215090-5A patent/BR0215090A/pt not_active IP Right Cessation
- 2002-12-18 JP JP2003552714A patent/JP3810770B2/ja not_active Expired - Fee Related
- 2002-12-18 TW TW091136517A patent/TW200410678A/zh unknown
- 2002-12-18 UA UA20040604534A patent/UA80407C2/uk unknown
- 2002-12-19 AR ARP020105003A patent/AR038046A1/es not_active Application Discontinuation
-
2004
- 2004-06-08 IS IS7303A patent/IS7303A/is unknown
- 2004-06-09 ZA ZA200404585A patent/ZA200404585B/en unknown
- 2004-07-16 CO CO04068143A patent/CO5590908A2/es not_active Application Discontinuation
- 2004-07-16 NO NO20043084A patent/NO20043084L/no not_active Application Discontinuation
-
2005
- 2005-01-25 HK HK05100665.9A patent/HK1068866A1/xx not_active IP Right Cessation
-
2006
- 2006-03-20 JP JP2006077296A patent/JP2006241162A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| UA80407C2 (en) | 2007-09-25 |
| JP2006241162A (ja) | 2006-09-14 |
| CN100343229C (zh) | 2007-10-17 |
| US20050215630A1 (en) | 2005-09-29 |
| PL370623A1 (en) | 2005-05-30 |
| WO2003051826A1 (en) | 2003-06-26 |
| EP1458677B1 (de) | 2009-04-15 |
| CA2470066A1 (en) | 2003-06-26 |
| EP1458677A1 (de) | 2004-09-22 |
| KR20040068589A (ko) | 2004-07-31 |
| CN1620430A (zh) | 2005-05-25 |
| HK1068866A1 (en) | 2005-05-06 |
| CA2470066C (en) | 2007-04-10 |
| HUP0402093A2 (hu) | 2005-02-28 |
| ES2324025T3 (es) | 2009-07-29 |
| SE0104333D0 (sv) | 2001-12-19 |
| NZ533365A (en) | 2006-05-26 |
| MXPA04005992A (es) | 2004-09-27 |
| AU2002352426A1 (en) | 2003-06-30 |
| JP3810770B2 (ja) | 2006-08-16 |
| CO5590908A2 (es) | 2005-12-30 |
| IL162378A0 (en) | 2005-11-20 |
| US7276539B2 (en) | 2007-10-02 |
| AR038046A1 (es) | 2004-12-22 |
| HUP0402093A3 (en) | 2008-08-28 |
| JP2005511785A (ja) | 2005-04-28 |
| IS7303A (is) | 2004-06-08 |
| NO20043084L (no) | 2004-07-16 |
| ATE428691T1 (de) | 2009-05-15 |
| BR0215090A (pt) | 2004-11-16 |
| TW200410678A (en) | 2004-07-01 |
| ZA200404585B (en) | 2005-10-26 |
| RU2004117776A (ru) | 2006-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE323072T1 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
| DE60104978D1 (de) | Selektive kristallisierung von 3-pyridyl-1-hydroxyethyliden-1,1-bisphosphonsäure natrium als hemipentahydrat oder monohydrat | |
| DE60238794D1 (de) | Hydantoinderivate als MMP-Inhibitoren | |
| ATE370938T1 (de) | Pro-pharmakon von cox-2-inhibitoren | |
| AR028567A1 (es) | Nuevos derivados de fenil-propargileter | |
| DE602004008303D1 (de) | Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3 | |
| NO20031784D0 (no) | Heteroarylalkylpiperazinderivater som fettsyre- oksydasjonsinhibitorer | |
| CY2009011I1 (el) | Αλατα προσθηκης οξεος παραγωγων υδροπυριδινης | |
| NO20040356L (no) | Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling. | |
| AR028596A1 (es) | Nuevos derivados de fenilglicina | |
| NO20033618L (no) | Ftalayinon-piperidino-derivater som PDE-4-inhibitorer | |
| DE69906311D1 (de) | Diarylbenzopyranderivate als cyclooxygenase-2-inhibitoren | |
| EE04240B1 (et) | (S)-omeprasooli kaaliumisool | |
| IS6987A (is) | Nýjar súlfónsýru afleiður | |
| DE50213681D1 (de) | Wässrige Lösung von Ascorbinsäure | |
| ATE304997T1 (de) | Derivate von beta-aminosäurenitrilen | |
| DE60008524D1 (de) | Furanonderivate als inhibitoren von cathepsin s | |
| HK1068866A1 (en) | 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha | |
| DE60218213D1 (de) | Pyridyloxyalkancarbonsäureamid-derivate verwendbar als fungizide | |
| ATE430726T1 (de) | N-acylamino-benzyletherderivate als selektive inhibitoren der monoaminoxidase b | |
| NO20021959L (no) | Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer | |
| ATE309994T1 (de) | Alkoxycarbonylaminobenzoesäure- oder alkoxycarbonylaminotetrazolylphenylderivate als ip-antagonisten | |
| DE60326720D1 (de) | Sulfonsäuresalze von Mandelsäurederivaten | |
| NO20035206D0 (no) | Pyrimidin-derivater anvendelige som selektive COX-2- inhibitorer | |
| DE60031450D1 (de) | Polymorph v von torasemid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |